The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone

E-ISSN： 1875-5607|9|9|1052-1063

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.9, 2009-08, pp. : 1052-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tiludronate. A new treatment for an old ailment: Paget’s disease of bone

By Morales-Piga A.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 157-170

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic Acid: A Review of its Use in the Treatment of Paget's Disease of Bone

By Keating Gillian M. Scott Lesley J.

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 793-804

Adis International

Access to resources Recommend Favorite

Treatment of Patients with Paget's Disease of Bone

By Roux C. Dougados M.

Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. : 823-830

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence

By Dodel Richard

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 513-528

Adis International

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-01 ,pp. : 4570-4582

Bentham Science Publishers

Access to resources Recommend Favorite